Resmed (RMD) Retained Earnings (2010 - 2026)

Resmed has reported Retained Earnings for 17 years, with the latest figure at $7.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 20.41% year-over-year to $7.0 billion; the trailing twelve-month figure through Mar 2026 stood at $7.0 billion (up 20.41% YoY), and the FY2025 full-year result was $6.1 billion, up 2517.81% from the prior year.
• Retained Earnings for Q1 2026 stood at $7.0 billion, up from -$29.9 million in the prior quarter.
• The five-year high for Retained Earnings was $7.0 billion in Q1 2026, with the low at -$320.1 million in Q3 2023.
• Historically, Retained Earnings has averaged $2.0 billion across 5 years, with a median of -$60.7 million in 2025.
• Annual changes were most pronounced in 2023 — Retained Earnings slumped 108.52% — and 2024, when it soared 2735.94%.
• Resmed's Retained Earnings stood at -$270.2 million in 2022, then gained by 22.88% to -$208.4 million in 2023, then soared by 2735.94% to $5.5 billion in 2024, then plunged by 100.54% to -$29.9 million in 2025, then jumped by 23402.34% to $7.0 billion in 2026.
• The last three Retained Earnings figures came in at $7.0 billion (Q1 2026), -$29.9 million (Q4 2025), and -$60.7 million (Q3 2025), per Business Quant data.